BALANCE SHEETS - USD ($)	Sep. 30, 2023	Sep. 30, 2022
Current assets:
Cash and cash equivalents	$ 4,145,735	$ 22,672,138
Prepaid expenses	520,368	762,063
Supplies used for R&D and manufacturing	2,248,072	2,001,715
Deposits	4,245	0
Total current assets	6,918,420	25,435,916
Finance lease right of use assets	9,131,987	10,937,797
Operating lease right of use assets	1,698,243	1,884,464
Property and equipment, net	10,188,126	11,889,029
Patent costs, net	197,704	212,201
Deposits	2,319,101	0
Supplies used for R&D and manufacturing	74,669	164,299
Total assets	30,528,250	50,523,706
Current Liabilities:
Accounts payable	2,009,786	1,618,290
Accrued expenses	1,049,581	842,492
Due to employees	557,244	471,488
Finance lease obligation, current portion	1,771,804	1,560,553
Operating lease obligation, current portion	197,431	170,928
Total current liabilities	5,585,846	4,663,751
Finance lease liabilities, net of current portion	9,949,565	11,721,368
Operating lease liabilities, net of current portion	1,652,949	1,850,380
Other liabilities	125,000	125,000
Total liabilities	17,313,360	18,360,499
STOCKHOLDERS' EQUITY
Preferred stock, $.01 par value; 200,000 shares authorized; 0 shares issued and outstanding Common stock, $.01 par value; 600,000,000 shares authorized; 47,422,304 and 43,448,317 shares issued and outstanding at September 30, 2023 and September 30, 2022, respectively	474,223	434,484
Additional paid-in capital	499,832,063	486,625,816
Accumulated deficit	(487,091,396)	(454,897,093)
Total stockholders' equity	13,214,890	32,163,207
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 30,528,250	$ 50,523,706